From acute injury to chronic disease: Pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD

Nephrology Dialysis Transplantation

Volumn 27, Issue SUPPL. 3, 2012, Pages

  Prunotto, Marco ^a   Budd, David C ^b   Meier, Matthias ^a   Formentini, Ivan ^d   Hartmann, Guido ^a   Pomposiello, Silvia ^a   Moll, Solange ^c  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b HOFFMANN LA ROCHE INC   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d NONE

Author keywords

epithelial cells; epithelial mesenchymal unit; fibrosis; myofibroblasts

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; OSTEOGENIC PROTEIN 1;

ACUTE KIDNEY FAILURE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATORY CELL; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE EPITHELIUM; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ACUTE KIDNEY INJURY; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 84868526635     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs283     Document Type: Review

References (104)

1. Amdur RL, Chawla LS, Amodeo S et al. Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int 2009; 76: 1089-1097.
2. Ishani A, Xue JL, Himmelfarb J et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223-228.
3. Lo LJ, Go AS, Chertow GM et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009; 76: 893-899.
4. Wald R, Quinn RR, Luo J et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. J Am Med Assoc 2009; 302: 1179-1185.
5. Chawla LS, Amdur RL, Amodeo S et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79: 1361-1369.
6. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKI Truly Lead to CKD? J Am Soc Nephrol 2012; 23: 979-984.
7. Srisawat N, Kellum JA. Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care 2011; 17: 548-555.
8. System USRD. Annual Data Report http://www.usrds.org/2010/view/v1-08.asp.
9. Kwon SH, Noh H, Jeon JS et al. An assessment of AKIN criteria for hospital-acquired acute kidney injury: a prospective observational cohort study. Nephron Clin Pract 2010; 116: c217-c223.
10. Kellum JA, Levin N, Bouman C et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002; 8: 509-514.
11. Go AS, Parikh CR, Ikizler TA et al. The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESSAKI) study: design and methods. BMC Nephrol 2010; 11: 22.
12. Hsu CY, Vittinghoff E, Lin F et al. The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141: 95-101.
13. Hsu CY, McCulloch CE, Fan D et al. Community-based incidence of acute renal failure. Kidney Int 2007; 72: 208-212.
14. Macedo E, Bouchard J, Mehta RL. Renal recovery following acute kidney injury. Curr Opin Crit Care 2008; 14: 660-665.
15. Bohle A, Muller GA, Wehrmann M et al. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 1996; 54: S2-S9.
16. Fine LG, Ong AC, Norman JT. Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993; 23: 259-265.
17. Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol 2006; 17: 2964-2966.
18. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2012; 21: 1819-1834.
19. Lewis MP, Fine LG, Norman JT. Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int 1996; 49: 48-58.
20. Johnson DW, Saunders HJ, Baxter RC et al. Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 1998; 54: 747-757.
21. Abbate M, Zoja C, Rottoli D et al. Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int 2002; 61: 2066-2077.
22. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543, 1p following 143.
23. Udo K, Aoki S, Uchihashi K et al. Adipose tissue explants and MDCK cells reciprocally regulate their morphogenesis in coculture. Kidney Int 2010; 78: 60-68.
24. Fine LG, Norman JT, Ong A. Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis. Kidney Int Suppl 1995; 49: S48-S50.
25. Alpers CE, Hudkins KL, Floege J et al. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994; 5: 201-209.
26. Wolf G, Neilson EG. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 1991; 39: 401-420.
27. Qi W, Chen X, Poronnik P et al. The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int J Biochem Cell Biol 2006; 38: 1-5.
28. Kaissling B, Le Hir M. The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 2008; 130: 247-262.
29. Alexakis C, Maxwell P, Bou-Gharios G. Organ-specific collagen expression: implications for renal disease. Nephron Exp Nephrol 2006; 102: e71-e75.
30. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
31. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2012; 27: 183-193.
32. Kaissling B, Le Hir M. Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 1994; 45: 709-720.
33. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990; 63: 144-161.
34. Hashizume T, Imayama S, Hori Y. Scanning electron microscopic study on dendritic cells and fibroblasts in connective tissue. Journal of electron microscopy 1992; 41: 434-437.
35. Maxwell PH, Ferguson DJ, Nicholls LG et al. The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 1997; 52: 715-724.
36. Rodemann HP, Muller GA. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am J Kidney Dis 1991; 17: 684-686.
37. Tomasek JJ, Gabbiani G, Hinz B et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-363.
38. Chang HY, Chi JT, Dudoit S et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
39. Simian M, Hirai Y, Navre M et al. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001; 128: 3117-3131.
40. Lemley KV, Kriz W. Anatomy of the renal interstitium. Kidney Int 1991; 39: 370-381.
41. Bohle A, Christ H, Grund KE et al. The role of the interstitium of the renal cortex in renal disease. Contrib Nephrol 1979; 16: 109-114.
42. Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010; 21: 1819-1834.
43. Hinz B, Phan SH, Thannickal VJ et al. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170: 1807-1816.
44. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
45. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2011; 21: 1247-1253.
46. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006; 8: 145-150.
47. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27: 549-550.
48. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
49. Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179: 1074-1080.
50. Zeisberg EM, Potenta SE, Sugimoto H et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287.
51. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
52. Flier SN, Tanjore H, Kokkotou EG et al. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 2010; 285: 20202-20212.
53. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGFbeta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
54. Dudas PL, Argentieri RL, Farrell FX. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells. Nephrol Dial Transplant 2009; 24: 1406-1416.
55. Murray LA, Hackett TL, Warner SM et al. BMP-7 does not protect against bleomycin-induced lung or skin fibrosis. PloS One 2008; 3: e4039.
56. Nath KA, Croatt AJ, Haggard JJ et al. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int 2000; 57: 2423-2433.
57. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543, 1p following 143.
58. Dagher PC, Mai EM, Hato T et al. The p53 inhibitor pifithrinalpha can stimulate fibrosis in a rat model of ischemic acute kidney injury. Am J Physiol Renal Physiol 2012; 302: F284-F291.
59. Liu G, Park YJ, Tsuruta Y et al. p53 Attenuates lipopolysaccharide- induced NF-kappaB activation and acute lung injury. J Immunol 2009; 182: 5063-5071.
60. Mitchell RA, Liao H, Chesney J et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002; 99: 345-350.
61. Plotnikov EY, Khryapenkova TG, Galkina SI et al. Cytoplasm and organelle transfer between mesenchymal multipotent stromal cells and renal tubular cells in co-culture. Exp Cell Res 2010; 316: 2447-2455.
62. Lindoso RS, Araujo DS, Adao-Novaes J et al. Paracrine interaction between bone marrow-derived stem cells and renal epithelial cells. Cell Physiol Biochem 2011; 28: 267-278.
63. Koesters R, Kaissling B, Lehir M et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177: 632-643.
64. Shilo BZ, Schejter ED. Regulation of developmental intercellular signalling by intracellular trafficking. EMBO J 2011; 30: 3516-3526.
65. Bielesz B, Sirin Y, Si H et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054.
66. Gould SE, Day M, Jones SS et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60.
67. Simon M, Maresh JG, Harris SE et al. Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 1999; 276: F382-F389.
68. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001; 12: 2392-2399.
69. Vukicevic S, Basic V, Rogic D et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 1998; 102: 202-214.
70. Morrissey J, Hruska K, Guo G et al. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13 (Suppl 1): S14-S21.
71. Manson SR, Niederhoff RA, Hruska KA et al. Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries. Am J Physiol Renal Physiol 2011; 301: F1293-F1302.
72. Hruska KA, Guo G, Wozniak M et al. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 2000; 279: F130-F143.
73. Sugimoto H, Lebleu VS, Bosukonda D et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 2012; 18: 396-404.
74. Tu Z, Shi Y, Wang J et al. Upregulation of connective tissue growth factor in a rat model of chronic allograft nephropathy. Nephrology 2007; 12: 166-171.
75. Okada H, Kikuta T, Kobayashi T et al. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2005; 16: 133-143.
76. Inoue T, Okada H, Kobayashi T et al. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 2003; 17: 268-270.
77. Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 2008; 74: 860-866.
78. Fujiu K, Manabe I, Nagai R. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 2011; 121: 3425-3441.
79. Zhang ZX, Shek K, Wang S et al. Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J Immunol 2010; 185: 967-973.
80. Zeisberg M, Strutz F, Muller GA. Renal fibrosis: an update. Curr Opin Nephrol Hypertens 2001; 10: 315-320.
81. Wang S, LaPage J, Hirschberg R. Proteinuria and progression of chronic renal disease. Kidney Blood Press Res 2000; 23: 167-169.
82. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118: 3522-3530.
83. Lange-Sperandio B, Fulda S, Vandewalle A et al. Macrophages induce apoptosis in proximal tubule cells. Pediatric Nephrol 2003; 18: 335-341.
84. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-850.
85. Johnston JR, Brenner BM, Hebert SC. Uninephrectomy and dietary protein affect fluid absorption in rabbit proximal straight tubules. Am J Physiol 1987; 253(2 Pt 2): F222-F233.
86. Venkatachalam MA, Griffin KA, Lan R et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F1078-F1094.
87. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17: 2974-2984.
88. Megyesi J, Price PM, Tamayo E et al. The lack of a functional p21 (WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci USA 1999; 96: 10830-10835.
89. Harper JW, Adami GR, Wei N et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
90. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-447.
91. Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy 2010; 65: 537-553.
92. Khalil N, O'Connor RN, Unruh HW et al. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991; 5: 155-162.
93. Antoniades HN, Bravo MA, Avila RE et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990; 86: 1055-1064.
94. Nash JR, McLaughlin PJ, Butcher D et al. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology 1993; 22: 343-7.
95. Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2003; 29(3 Suppl): S93-S97.
96. Young L, Adamson IY. Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ Health Perspect 1993; 101: 56-61.
97. Ziyadeh FN, Hoffman BB, Han DC et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000; 97: 8015-8020.
98. McCormick LL, Zhang Y, Tootell E et al. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graftversus-host disease: a model for human scleroderma. J Immunol 1999; 163: 5693-5699.
99. Fukasawa H, Yamamoto T, Suzuki H et al. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling. Kidney Int 2004; 65: 63-74.
100. Denton CP, Merkel PA, Furst DE et al. Recombinant human antitransforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 2007; 56: 323-333.
101. Ko GJ, Boo CS, Jo SK et al. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2008; 23: 842-852.
102. Kim MG, Boo CS, Ko YS et al. Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusioninduced acute kidney injury. Nephrol Dial Transplant 2010; 25: 2908-2921.
103. Lebleu VS, Sugimoto H, Miller CA et al. Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease. Lab Invest 2008; 88: 284-292.
104. Gandolfo MT, Jang HR, Bagnasco SM et al. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 2009; 76: 717-729.